Sign In
Buy ASRT
$23.47
+0.0200 (+0.0853%)
At Close: Jun 03, 2026
Assertio Therapeutics, Inc. (“Assertio” or “the Company”) (ASRT) today announced the date of its 2020 Annual Meeting, which will be held as a virtual meeting on May 19, 2020. The Company also
Activist hedge fund Starboard pounces on U.S. companies in turmoil
07:00pm, Wednesday, 15'th Apr 2020
Most activist shareholders have refrained from challenging the boards of U.S. companies during this season of annual shareholder meetings, as businesses reel from the economic fallout of the coronavir
UPDATE 1-Activist hedge fund Starboard pounces on U.S. companies in turmoil
06:44pm, Wednesday, 15'th Apr 2020
Most activist shareholders have refrained from challenging the boards of U.S. companies during this season of annual shareholder meetings, as businesses reel from the economic fallout of the coronavir
Activist hedge fund Starboard pounces on U.S. companies in turmoil
06:04am, Wednesday, 15'th Apr 2020
Most activist shareholders have refrained from challenging the boards of U.S. companies during this season of annual shareholder meetings, as businesses reel from the economic fallout of the coronavir
Activist hedge fund Starboard pounces on U.S. companies in turmoil
06:00am, Wednesday, 15'th Apr 2020
Most activist shareholders have refrained from challenging the boards of U.S. companies during this season of annual shareholder meetings, as businesses reel from the economic fallout of the coronavir
Assertio Therapeutics, Inc. (“Assertio” or the “Company”) (ASRT), today announced the completion and final results for its cash tender offers (the “Offers”) to purchase any and all of the
Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Have A Particularly Volatile Share Price?
10:24am, Thursday, 02'nd Apr 2020
If you're interested in Assertio Therapeutics, Inc. (NASDAQ:ASRT), then you might want to consider its beta (a measure...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
11:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) * BioNTech SE - ADR (NASDAQ: BNTX) * Regeneron P
Wayne-based drug company enters into $17.5M merger deal
03:41pm, Tuesday, 17'th Mar 2020
Zyla Life Sciences (OTCQX: ZCOR), a Wayne-based specialty pharmaceutical company that focuses on non-opioid pain products, has entered into a definitive merger agreement with Assertio Therapeutics. Z
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – WLTW, TTPH, ASRT, MEET
02:15pm, Tuesday, 17'th Mar 2020
NEW YORK, March 17, 2020 -- Halper Sadeh LLP, a global investor rights law firm, investigates whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP.
Assertio Therapeutics, Inc. (“Assertio” or “the Company”) (ASRT) and Zyla Life Sciences (“Zyla”) (ZCOR), today announced that they have entered into a definitive merger agreement (the “A
PDL BioPharma (PDLI) Misses on Q4 Earnings, To Dissolve by Year-End
04:16pm, Thursday, 12'th Mar 2020
PDL BioPharma's (PDLI) earnings lag estimates in the fourth quarter. The company announces plan to complete liquidation by the end of 2020.
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
